HTBA enters US market with Specnova buyout
HTBA has bought Specnova, a US biotech known for its ingredient delivery tech. The deal marks HTBA’s first step into America and expands both firms’ reach and technology.
Drug Delivery 1 article
A therapeutic can only act where and when it reaches the relevant tissue, cell or intracellular compartment. Drug Delivery examines formulations and delivery technologies such as nanoparticles, lipid systems, controlled release, targeted delivery and route-of-administration strategies, with biodistribution and safety as core constraints. The section is modality-agnostic but delivery-centered; molecular design or target biology belongs elsewhere unless the delivery system is the factor determining therapeutic performance.